Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
- Status
- TERMINATED
- Phase
- PHASE2
A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers
- Status
- COMPLETED
- Phase
- N/A
Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
- Status
- COMPLETED
- Phase
- PHASE2
LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer
- Status
- COMPLETED
- Phase
- NA
A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Total/Subtotal Colectomy in Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Long-Term Responders on Olaparib
- Status
- COMPLETED
- Phase
- N/A